Agilent Bets On Pathology Innovation With Biocare Acquisition [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Agilent Technologies Inc. shares are up during Monday's premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Synergies Biocare Medical has been a prominent player in the pathology space, offering a range of immunohistochemistry and hybridization solutions. Biocare has over 300 specialized antibodies and robust R&D capabilities. It has consistently achieved double-digit revenue and profit growth since 2021, making it a valuable addition to Agilent's offerings. Don't Miss: This Energy Storage Company Already Has $185M in Contracts—Shares Are Still Available Fast Company Calls It a ‘Groundbreaking Step for the Creator Economy' — Investors Can Still Get In at $0.85/Share The addition of Biocare's IHC antibodies, reagents, and instrument portfolio strengthens Agilent's immunohistochemistry offering and broadens its reach across clinical and research pathology labs. Agilent expects Biocare's strong growth in the IHC market
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026Business Wire
- Assessing Agilent Technologies (A) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Emerald Growth Equity Strategy Sold Agilent (A) Due to Compression in the Margin of Safety [Yahoo! Finance]Yahoo! Finance
- Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States [Yahoo! Finance]Yahoo! Finance
- Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United StatesBusiness Wire
A
Earnings
- 2/25/26 - Miss
A
Sec Filings
- 3/20/26 - Form 8-K
- 3/6/26 - Form 8-K
- 3/3/26 - Form 10-Q
- A's page on the SEC website